Cocrystal Pharma Inc (COCP)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current COCP market cap is 19.33M. The company's latest EPS is USD -1.7677 and P/E is -1.11.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.6M | 1M | 0 | 0 | 0 |
| Operating Income | -4.44M | -4.73M | -4.16M | -5.45M | -5.04M |
| Net Income | -4.17M | -4.46M | -3.96M | -5.34M | -4.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.56M | 2.01M | 0 | 0 | 2.6M |
| Operating Income | -48.41M | -9.59M | -14.22M | -19.74M | -18.56M |
| Net Income | -48.17M | -9.65M | -14.19M | -38.84M | -17.98M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 32.61M | 31.26M | 26.55M | 21.57M | 16.23M |
| Total Liabilities | 1.92M | 4.88M | 3.96M | 4.18M | 3.53M |
| Total Equity | 30.69M | 26.38M | 22.59M | 17.39M | 12.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 28.53M | 54.24M | 79.39M | 40.84M | 31.26M |
| Total Liabilities | 2.82M | 1.74M | 1.84M | 1.27M | 4.88M |
| Total Equity | 25.71M | 52.51M | 77.55M | 39.57M | 26.38M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.34M | -14.67M | -4.5M | -8.2M | -13.33M |
| Investing | -59k | -118k | -8k | -8k | -8k |
| Financing | 3.99M | 3.99M | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.56M | -9.83M | -12.72M | -21.44M | -14.67M |
| Investing | -145k | -240k | -52k | -74k | -118k |
| Financing | 6.42M | 35.66M | 38.47M | -27k | 3.99M |
| Market Cap | 19.33M |
| Price to Earnings Ratio | -1.11 |
| Price to Sales Ratio | 7.71 |
| Price to Cash Ratio | 0.76 |
| Price to Book Ratio | 0.76 |
| Dividend Yield | - |
| Shares Outstanding | 10.17M |
| Average Volume (1 week) | 40.53k |
| Average Volume (1 Month) | 31.94k |
| 52 Week Change | 32.87% |
| 52 Week High | 3.26 |
| 52 Week Low | 1.35 |
| Spread (Intraday) | 0.04 (2.11%) |
| Company Name | Cocrystal Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.cocrystalpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
